Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.

Dahdal S, Devetzis V, Chalikias G, Tziakas D, Chizzolini C, Ribi C, Trendelenburg M, Eisenberger U, Hauser T, Pasch A, Huynh-Do U, Arampatzis S; Swiss Systemic Lupus Erythematosus Cohort Study Group.

PLoS One. 2018 Jan 24;13(1):e0188695. doi: 10.1371/journal.pone.0188695. eCollection 2018.

2.

The Incidence and the Prognostic Impact of Acute Kidney Injury in Acute Myocardial Infarction Patients: Current Preventive Strategies.

Kaltsas E, Chalikias G, Tziakas D.

Cardiovasc Drugs Ther. 2018 Feb;32(1):81-98. doi: 10.1007/s10557-017-6766-6.

PMID:
29349645
3.

Role of CYP4F2, CYP2C19, and CYP1A2 polymorphisms on acenocoumarol pharmacogenomic algorithm accuracy improvement in the Greek population: need for sub-phenotype analysis.

Ragia G, Karantza IM, Kelli-Kota E, Kolovou V, Kolovou G, Konstantinides S, Maltezos E, Tavridou A, Tziakas D, Maitland-van der Zee AH, Manolopoulos VG.

Drug Metab Pers Ther. 2017 Dec 20;32(4):183-190. doi: 10.1515/dmpt-2017-0034.

PMID:
29252193
4.

A patient with an extensive coronary artery thrombus.

Chalikias G, Kikas P, Thomaidis A, Serif L, Georgiadis GS, Tziakas D.

Hellenic J Cardiol. 2017 Nov 7. pii: S1109-9666(17)30471-2. doi: 10.1016/j.hjc.2017.11.002. [Epub ahead of print] No abstract available.

5.

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators.

N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27.

6.

Cognitive Function in a Randomized Trial of Evolocumab.

Giugliano RP, Mach F, Zavitz K, Kurtz C, Im K, Kanevsky E, Schneider J, Wang H, Keech A, Pedersen TR, Sabatine MS, Sever PS, Robinson JG, Honarpour N, Wasserman SM, Ott BR; EBBINGHAUS Investigators.

N Engl J Med. 2017 Aug 17;377(7):633-643. doi: 10.1056/NEJMoa1701131.

7.

Novel echocardiographic prognostic markers for cardiac tamponade in patients with large malignant pericardial effusions: A paradigm shift from flow to tissue imaging.

Chalikias G, Samaras A, Ziakas A, Kikas P, Thomaidis A, Drosos I, Giannakoulas G, Karvounis H, Konstantinides S, Tziakas D.

Echocardiography. 2017 Sep;34(9):1315-1323. doi: 10.1111/echo.13620. Epub 2017 Jul 7.

PMID:
28685870
8.

C-terminal fragment of agrin (CAF) levels predict acute kidney injury after acute myocardial infarction.

Arampatzis S, Chalikias G, Devetzis V, Konstantinides S, Huynh-Do U, Tziakas D.

BMC Nephrol. 2017 Jun 24;18(1):202. doi: 10.1186/s12882-017-0611-9.

9.

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR; FOURIER Steering Committee and Investigators.

N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17.

10.

A novel acenocoumarol pharmacogenomic dosing algorithm for the Greek population of EU-PACT trial.

Ragia G, Kolovou V, Kolovou G, Konstantinides S, Maltezos E, Tavridou A, Tziakas D, Maitland-van der Zee AH, Manolopoulos VG.

Pharmacogenomics. 2017 Jan;18(1):23-34. doi: 10.2217/pgs-2016-0126. Epub 2016 Dec 14.

PMID:
27967328
11.

Differences between perivascular adipose tissue surrounding the heart and the internal mammary artery: possible role for the leptin-inflammation-fibrosis-hypoxia axis.

Drosos I, Chalikias G, Pavlaki M, Kareli D, Epitropou G, Bougioukas G, Mikroulis D, Konstantinou F, Giatromanolaki A, Ritis K, Münzel T, Tziakas D, Konstantinides S, Schäfer K.

Clin Res Cardiol. 2016 Nov;105(11):887-900. Epub 2016 Jun 23.

PMID:
27337945
12.

Prevention of Contrast-Induced Acute Kidney Injury: an Update.

Chalikias G, Drosos I, Tziakas DN.

Cardiovasc Drugs Ther. 2016 Oct;30(5):515-524. Review.

PMID:
27541275
13.

Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.

Achimastos A, Alexandrides T, Alexopoulos D, Athyros V, Bargiota A, Bilianou E, Chrysochoou C, Drogari E, Elisaf M, Ganotakis E, Goudevenos I, Ioannidis I, Kolovou G, Kotsis V, Lekakis I, Liberopoulos E, Melidonis A, Nikolaou V, Ntaios G, Papanas N, Pappas S, Pitsavos C, Rallidis L, Richter D, Skoumas I, Tentolouris N, Tousoulis D, Tselepis A, Tsioufis K, Tziakas D, Tziomalos K, Vardas P, Vlachopoulos C, Vlahakos D.

Hormones (Athens). 2016 Jan-Mar;15(1):8-14. doi: 10.14310/horm.2002.1659.

14.

Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.

O'Donoghue ML, Glaser R, Cavender MA, Aylward PE, Bonaca MP, Budaj A, Davies RY, Dellborg M, Fox KA, Gutierrez JA, Hamm C, Kiss RG, Kovar F, Kuder JF, Im KA, Lepore JJ, Lopez-Sendon JL, Ophuis TO, Parkhomenko A, Shannon JB, Spinar J, Tanguay JF, Ruda M, Steg PG, Theroux P, Wiviott SD, Laws I, Sabatine MS, Morrow DA; LATITUDE-TIMI 60 Investigators.

JAMA. 2016 Apr 19;315(15):1591-9. doi: 10.1001/jama.2016.3609.

PMID:
27043082
15.

Contrast-Induced Acute Kidney Injury: An Update.

Chalikias G, Drosos I, Tziakas DN.

Cardiovasc Drugs Ther. 2016 Apr;30(2):215-28. doi: 10.1007/s10557-015-6635-0. Review.

PMID:
26780748
16.

Applying Evidence-Based Medicine in Actual Clinical Practice: Can We Bridge the Gap? A Review of the Literature.

Argyriou C, Georgiadis GS, Georgakarakos EI, Roumeliotis S, Roumeliotis A, Kikas P, Tziakas D, Lazarides MK.

Hellenic J Cardiol. 2015 Sep-Oct;56(5):373-8. Review. No abstract available.

17.

Spot urine albumin to creatinine ratio outperforms novel acute kidney injury biomarkers in patients with acute myocardial infarction.

Tziakas D, Chalikias G, Kareli D, Tsigalou C, Risgits A, Kikas P, Makrygiannis D, Chatzikyriakou S, Kampouromiti G, Symeonidis D, Voudris V, Konstantinides S.

Int J Cardiol. 2015 Oct 15;197:48-55. doi: 10.1016/j.ijcard.2015.06.019. Epub 2015 Jun 18.

PMID:
26113474
18.

The effect of Frappe coffee on blood lipid levels.

Mirkopoulou D, Tziakas D, Maltezos E.

Hippokratia. 2015 Oct-Dec;19(4):383. No abstract available.

19.

Ivabradine in stable coronary artery disease without clinical heart failure.

Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R; SIGNIFY Investigators.

N Engl J Med. 2014 Sep 18;371(12):1091-9. doi: 10.1056/NEJMoa1406430. Epub 2014 Aug 31.

20.

Biomarkers of the extracellular matrix and of collagen fragments.

Chalikias GK, Tziakas DN.

Clin Chim Acta. 2015 Mar 30;443:39-47. doi: 10.1016/j.cca.2014.06.028. Epub 2014 Jul 5. Review.

PMID:
25007952

Supplemental Content

Loading ...
Support Center